Impact of Beta Blockers on TAVI (BETA-TAVI)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 348 participants.

Also called NCT05721170

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 348 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05721170
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Cyprus, Greece (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05721170. Randomized; no masking; primary purpose treatment. Start 2024-06-01 (actual); primary completion 2028-01-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Impact of Beta Blockers on TAVI (BETA-TAVI)
Acronym
BETA-TAVI
Condition
Aortic Valve Stenosis
Intervention (Drug)
Beta blocker
Lead sponsor
National and Kapodistrian University of Athens (class: other)
Collaborator
Evangelismos Hospital (class: other)
Collaborator
Interbalkan Medical Center, Thessaloniki, Greece (class: not stated)

Record details

Record id
cardio:ct-nct05721170
Content hash
e2f19a3ed529dace4453b060217bffeba353ae5820cb24ae4dd097c79d5e6f3f